Table 1.
Your clinical or policy question | RWE study question | |
---|---|---|
Population | Patients 65+ with type 2 diabetes | Patients 40–65 with diagnosis of type 2 diabetes measured in the 180 days prior to and including the date of treatment initiation |
Intervention | Drug X | Drug X |
Comparator | Drug Y | Drug Z |
Outcome | Hospitalization for heart failure | Hospitalization with heart failure diagnosis as primary discharge diagnosis |
Timing | On-treatment follow-up Starts: Day after treatment initiation Stops: End of treatment, switching therapies, death or disenrollment |
Intention-to-treat follow-up Starts: Day after treatment initiation Stops: Death, disenrollment, 730 days after initiation |
PICOT, Population, Intervention, Comparator, Outcome, and Timing; RWE, real-world evidence.